Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/ebqTCrsecrzGhKcNdhnQ

  ADVERTISEMENT  
December 5, 2012News for the transfusion medicine and cellular therapy community

  Top Story 
 
  • Stem cells could be tested as treatment for lung conditions
    Canadian researchers used human umbilical cord stem cells to protect newborn rats' lungs. The cells were able to identify and correct problems such as inflammation. Such cells could be used to treat lung diseases in newborns and adults in the future, according to the study published in the medical journal Thorax. Researchers are preparing to test the treatment in 20 people in the next two years. Metro (Canada) (12/4) LinkedInFacebookTwitterEmail this Story
  ADVERTISEMENT  
NEW Complement Coated C3 Control Cells!
Hemo bioscience has received FDA clearance for its complement coated control cells. Hemo bioscience C3 Control Cells can be used as a control to confirm the efficacy of the AHG reagent used during Direct and Indirect Anti-Globulin tests. For details regarding pricing, manufacturing schedule, and distribution channels email us or call 866-332-2835.

  Science & Health 
  • Study uses stem cells to treat glaucoma
    Researchers in the U.K. are studying a potential treatment for glaucoma that employs patients' own stem cells. Researchers reported a 50% reduction in the loss of optic nerve fibers with the infusion of olfactory ensheathing cells near the optic nerve. The method also lessened damage to optic nerve tissue. Researchers said the method may lead to a future technique that could prevent blindness from glaucoma. Medical News Today (12/4) LinkedInFacebookTwitterEmail this Story
  ADVERTISEMENT  
Patient Blood Management Resources from AABB
AABB offers a host of tools for transfusion decision makers. Clinical guidelines, education sessions and more. AABB Members can download Getting Started in Patient Blood Management and Citations in Patient Blood Management for FREE. Visit aabb.org/pbm for more information.

  Emerging Trends 
  Industry News & Practice 
  • WiCell to use Agilent microarrays in stem cell testing
    WiCell is incorporating Agilent Technologies' CGH+SNP microarrays into its product offering for comparative genomic hybridization and SNP analysis of mouse and human embryonic stem cells and induced pluripotent stem cells. Kathleen Shelton, senior director of genomics marketing at Agilent, said the collaboration will lead to capabilities "vital for research and commercial development." GenomeWeb Daily News (free registration) (12/4) LinkedInFacebookTwitterEmail this Story
  Government & Regulatory 
  • Obama administration says AIDS-free generation is achievable
    Secretary of State Hillary Rodham Clinton laid out a plan to achieve an AIDS-free generation during a State Department ceremony Thursday to recognize World AIDS Day. The framework calls for targeting high-risk populations, providing earlier treatment of HIV infections and implementing faster expansion of proven tools. Yahoo/The Associated Press (11/29) LinkedInFacebookTwitterEmail this Story
  • CMS urged to release final rule on sunshine law this month
    Medtronic and the Pew Charitable Trusts have asked CMS to issue a final rule this month governing the sunshine law, which mandates that med-tech firms and other health care companies report payments made to hospitals and doctors. "Many companies have already invested significant resources in preparing to comply with the sunshine provision," representatives wrote in a letter to CMS Acting Administrator Marilyn Tavenner. MassDevice.com (Boston) (12/3), Reuters (11/28) LinkedInFacebookTwitterEmail this Story
  Association News 
  • "Auditing in the Transfusion Service" available in AABB digital downloads library
    AABB has made "Auditing in the Transfusion Service" available in its Digital Downloads library. The publication begins with an overview of auditing fundamentals and also provides details on how to conduct transfusion service audits. The text is supplemented by sample forms, templates, charts and other tools that can be customized by each user. Purchasing information is available in the AABB Marketplace. LinkedInFacebookTwitterEmail this Story
Learn more about AABB® ->Homepage  |  Join AABB  |  Conferences  |  Marketplace

Position TitleCompany NameLocation
West Coast Account ManagerMacopharma USAUS - Nationwide
Director, LaboratorySan Diego Blood BankUS - CA - San Diego
Director, Patient Blood ManagementAABBUS - MD - Bethesda
Click here to view more job listings.

  SmartQuote 
The forceps of our minds are clumsy things and crush the truth a little in the course of taking hold of it."
--H.G. Wells,
British author


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Corporate Relations Manager:  Tamara Zein (240) 333-6604
Job Board: AABB CareerLink
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent AABB SmartBrief Issues:   Lead Editor:  Tom Parks
Managing Editor: Cristian Becker

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2012 SmartBrief, Inc.® Legal Information